💫 #CMR is useful for predicting SCD in NICM.

📊 DERIVATE 2.0 provides better risk classification, incorporating gender, LVEF, and amount/location of #LGE.

👉 Let's look beyond LVEF alone to determine which NICM patients get ICD.

Full text: doi.org/10.1093/ehjc...
#CMR @SCMR #cardiosky

⭐ What this means:
--Traditional screening tools miss many at-risk people
--Even when risks are recognized, preventive therapies often aren't started
--We need a better strategy to identify disease earlier

@DLBHATTMD #cardiotwitter #CAD #CCTA @SCCT
doi.org/10.1093/eurh...

🚨 Preventing first heart attacks may need a rethink.

🔬 In this massive study of 4.6 million people with their first heart attack:
--18% had no standard modifiable risk factors
--51% had no warning symptoms beforehand
--63% weren't on preventive meds (only 22% on statin)

💊 If positive, guidelines could rec #CCTA for asymptomatic adults, allowing us to detect and treat #CAD earlier to prevent more heart attacks.

🫀 To prepare, we need to model what a positive trial could mean for patient volumes and what it would take to meet that need.

🏴󠁧󠁢󠁳󠁣󠁴󠁿 #cardiosky

💥 The SCOT-HEART 2 trail could transform how we identify those at risk of heart attacks.

🔬 Trial randomizes asymptomatic patients ages 40-70 with ≥1 risk factors to either #CoronaryCTA or standard care, with appropriate therapies, looking for primary outcome of heart attack.

Superb article summarizing the knowns and unknowns of broken heart syndrome (Takotsubo syndrome).💔

Yes, emotions can stun the heart. A fascinating tale of mind–heart biology. Full text here: www.nature.com/articles/s41...

@elmir1omerovic #cardiotwitter

🚨Late-presenting ostial LAD STEMI, imaged 7-days later with #CMR. Here's the #LGE.
❓Would you call thrombus? Microvascular obstruction? Intramyocardial hemorrhage? Or a combination of these?
@NorthwellHealth @LenoxHill #cardiotwitter

❓As Plaque Analysis roles out nationwide for #CCTA, providers are asking "How will this change clinical management?"
✔️The DECIDE registry provides one framework: Total Plaque Volume determines level of therapy.
🔬More research is needed to show impact on hard outcomes.
#cardiotwitter @NorthwellHealth

This #CMR shows anteroapical intramyocardial enhancement.
Taking the image as a whole, what's one potential explanation?
#cardiotwitter #CardiacImaging

Important multicenter study in #EHJ
#CMR outperforms societal recs for ICD placement in cardiac sarcoidosis
📈AUC=0.86 for 5-yr risk of fatal/life-threatening arrhythmias
⚡Highest risk = abnl LVEF + LGE that is multifocal, septal, subepicardial, or involves RV freewall
buff.ly/Nc2upbU
#cardiotwitter

Nice review in #EHJ on LGE and SCD by @DrMarchlinski et al. buff.ly/GeU589P
🫀Good reminder that in CAD: LGE predicts SCD better than LVEF; absence of LGE has a high NPV for SCD
🔭Looking ahead, digital twins made from CMR data undergo virtual inductions to uncover arrhythmia risk
#cardiotwitter